Eloquest Healthcare News and Events

In 2019 and again in September of 2020, Eloquest Healthcare partnered with Adventist Health Global Missions to support their efforts of providing care and performing surgeries in remote communities abroad without access to these services.

Eloquest Healthcare is excited to announce new, 5-year MedSurg agreement with group purchasing organization Vizient Supply, LLC that will include Mastisol^® Liquid Adhesive, Detachol^® Adhesive Remover and ReliaTect^® Post-Op Dressing with CHG. Under the new agreement, Vizient members can take advantage of special pricing for these products.

Eloquest Healthcare is excited to announce our new partnership with TillaCare founded on a shared goal of reducing catheter-associated urinary tract infection (CAUTI) risk in U.S. hospitals.

Through collaboration, medical device companies can leverage each other’s strengths to satisfy patients and providers.

Eloquest Healthcare, Inc. is honored to announce today announced that it is Great Place to Work-Certified™ for 2019-2020!

Eloquest Healthcare, Inc. is honored to announce that Fortune and Great Place to Work have recognized us as one of the 2018 Best Workplaces in Health Care & Biopharma!

Vancive Medical Technologies™, an Avery Dennison (NYSE:AVY) business, and Eloquest Healthcare^®, Inc. have partnered to develop an innovative post-operative dressing that contains an antimicrobial agent called chlorhexidine gluconate (CHG). The antimicrobial properties of CHG inhibit microbial growth within the dressing

Eloquest Healthcare is proud to be named Great Place to Work and Fortune Magazine’s Best Workplaces for Small Medium Business Companies, read more about it here!

To raise awareness about the importance of infection prevention, Eloquest Healthcare is joining the Association for Professionals in Infection Control and Epidemiology (APIC) as a corporate Champion for International Infection Prevention Week (IIPW), October 15-21.